OFIX Orthofix Medical Inc
Price (delayed)
$14.19
Market cap
$553.73M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$3.3
Enterprise value
$643.6M
Orthofix Medical Inc. is a global medical device and biologics company with a spine and extremities focus. The Company's mission is to deliver innovative, quality-driven solutions as it partners with
Highlights
Orthofix Medical's quick ratio has increased by 35% QoQ and by 31% YoY
The gross profit has increased by 12% year-on-year and by 2.3% since the previous quarter
The EPS has grown by 20% YoY but it has contracted by 5% from the previous quarter
The net income has grown by 17% YoY but it has contracted by 6% from the previous quarter
Orthofix Medical's debt has soared by 55% YoY and by 28% from the previous quarter
The equity has contracted by 16% YoY and by 4.3% from the previous quarter
Key stats
What are the main financial stats of OFIX
Market
Valuations
Earnings
Shares outstanding
39.02M
Market cap
$553.73M
Enterprise value
$643.6M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.08
Price to sales (P/S)
0.68
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.81
Revenue
$799.49M
Gross profit
$545.89M
Operating income
-$84.62M
Net income
-$126M
EBIT
-$94.24M
EBITDA
-$34.18M
Free cash flow
-$9.09M
Per share
Balance sheet
Liquidity
EPS
-$3.3
EPS diluted
-$3.3
Free cash flow per share
-$0.24
Book value per share
$13.17
Revenue per share
$20.97
TBVPS
$15.72
Total assets
$893.29M
Total liabilities
$390.17M
Debt
$175.61M
Equity
$503.12M
Working capital
$264.66M
Debt to equity
0.35
Current ratio
2.57
Quick ratio
1.31
Net debt/EBITDA
-2.63
Margins
Efficiency
Dividend
EBITDA margin
-4.3%
Gross margin
68.3%
Net margin
-15.8%
Operating margin
-10.6%
Return on assets
-14.2%
Return on equity
-23.5%
Return on invested capital
-17.8%
Return on capital employed
-13%
Return on sales
-11.8%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
OFIX stock price
How has the Orthofix Medical stock price performed over time
Intraday
1.72%
1 week
8.9%
1 month
-14.05%
1 year
8.32%
YTD
-18.73%
QTD
-13%
Financial performance
How have Orthofix Medical's revenue and profit performed over time
Revenue
$799.49M
Gross profit
$545.89M
Operating income
-$84.62M
Net income
-$126M
Gross margin
68.3%
Net margin
-15.8%
The company's operating margin rose by 43% YoY and by 9% QoQ
The company's operating income rose by 39% YoY and by 7% QoQ
Orthofix Medical's net margin has increased by 22% YoY but it has decreased by 3.9% from the previous quarter
The net income has grown by 17% YoY but it has contracted by 6% from the previous quarter
Growth
What is Orthofix Medical's growth rate over time
Valuation
What is Orthofix Medical stock price valuation
P/E
N/A
P/B
1.08
P/S
0.68
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.81
The EPS has grown by 20% YoY but it has contracted by 5% from the previous quarter
The stock's price to book (P/B) is 28% less than its 5-year quarterly average of 1.5
The equity has contracted by 16% YoY and by 4.3% from the previous quarter
The price to sales (P/S) is 43% lower than the 5-year quarterly average of 1.2 and 2.9% lower than the last 4 quarters average of 0.7
The revenue is up by 7% year-on-year
Efficiency
How efficient is Orthofix Medical business performance
The ROIC has grown by 38% YoY and by 2.7% from the previous quarter
The ROS has grown by 37% YoY and by 4.8% from the previous quarter
OFIX's return on assets is up by 14% year-on-year but it is down by 7% since the previous quarter
OFIX's ROE is down by 11% QoQ but it is up by 2.1% YoY
Dividends
What is OFIX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for OFIX.
Financial health
How did Orthofix Medical financials performed over time
The total assets is 129% greater than the total liabilities
Orthofix Medical's quick ratio has increased by 35% QoQ and by 31% YoY
The company's total liabilities rose by 19% YoY and by 14% QoQ
Orthofix Medical's debt is 65% less than its equity
OFIX's debt to equity has soared by 84% YoY and by 35% from the previous quarter
Orthofix Medical's debt has soared by 55% YoY and by 28% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.